B
Bruce Neal
Researcher at The George Institute for Global Health
Publications - 620
Citations - 109123
Bruce Neal is an academic researcher from The George Institute for Global Health. The author has contributed to research in topics: Population & Blood pressure. The author has an hindex of 108, co-authored 561 publications receiving 87213 citations. Previous affiliations of Bruce Neal include National Institutes of Health & University of the Western Cape.
Papers
More filters
Journal ArticleDOI
Soluble Vascular Cell Adhesion Molecule 1 and N-terminal Pro–B-Type Natriuretic Peptide in Predicting Ischemic Stroke in Patients With Cerebrovascular Disease
Duncan J. Campbell,Mark Woodward,John Chalmers,Samuel A. Colman,Alicia J. Jenkins,Bruce E. Kemp,Bruce E. Kemp,Bruce E. Kemp,Bruce Neal,Anushka Patel,Stephen MacMahon +10 more
TL;DR: Measurement of sVCAM-1 and NT-proBNP levels provides prognostic information for recurrent ischemic stroke beyond traditional risk factors.
Journal ArticleDOI
No effect of low-dose aspirin for the prevention of heterotopic bone formation after total hip replacement: A randomized trial of 2,649 patients
Bruce Neal,Anthony Rodgers,Harley Gray,Taane G. Clark,Debbie D Beaumont,Tony House,J. Douglas,Ian R Reid,Stephen MacMahon +8 more
TL;DR: The balance of benefits and risks of low-dose aspirin is determined by its effects on vascular events and bleeding, since it has no major effects on heterotopic bone formation or associated clinical outcomes.
Journal ArticleDOI
Effects of blood pressure lowering on cardiovascular risk according to baseline body-mass index: a meta-analysis of randomised trials
Larry Agodoa,Ray Estacio,Robert W. Schrier,Jacobus Lubsen,John Chalmers,Jeffrey A. Cutler,Barry R. Davis,Lindon Wing,Neil R Poulter,Peter S. Sever,G. Remuzzi,Piero Ruggenenti,Steven E. Nissen,Lars H Lindholm,Tsuguya Fukui,Toshio Ogihara,Takao Saruta,Henry R. Black,Peter Sleight,Michel Lievre,Hiromichi Suzuki,Keith A.A. Fox,Liu Lisheng,Takayoshi Ohkubo,Yutaka Imai,Salim Yusuf,Christopher J. Bulpitt,Edmund J. Lewis,Matthew A. Brown,Colin N. A. Palmer,Ji-Guang Wang,Carl J. Pepine,Masao Ishii,Yoshiki Yui,Kizuku Kuramoto,M. Pfeff Er,Folkert W. Asselbergs,W. H. Van Gilst,B. Byington,Bertram Pitt,Barry M. Brenner,W. J. Remme,Dick de Zeeuw,Mahboob Rahman,Giancarlo Viberti,Koon K. Teo,Alberto Zanchetti,Ettore Malacco,G. Mancia,J.A. Staessen,Robert Fagard,Rury R. Holman,L. Hansson,John B. Kostis,Yoshihiko Kanno,Stephan Lueders,Masunori Matsuzaki,P. Poole-Wilson,Joachim Schrader,Kazem Rahimi,Craig S. Anderson,Neil Chapman,Rory Collins,Stephen MacMahon,Bruce Neal,Anthony Rodgers,Paul K. Whelton,Mark Woodward +67 more
TL;DR: Little evidence is found that selection of a particular class of blood pressure-lowering drug will lead to substantially different outcomes for individuals who are obese compared with those who are lean.
Journal ArticleDOI
Oral disease and subsequent cardiovascular disease in people with type 2 diabetes: a prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial.
Qiang Li,John Chalmers,Sébastien Czernichow,Sébastien Czernichow,Bruce Neal,B.A. Taylor,Sophia Zoungas,Sophia Zoungas,Neil R Poulter,Mark Woodward,Mark Woodward,Anushka Patel,B.E. de Galan,B.E. de Galan,George David Batty,George David Batty,George David Batty +16 more
TL;DR: In people with type 2 diabetes, oral disease, as indexed by fewer teeth, was related to an increased risk of death from all causes and of death due to CVD and non-CVD.
Journal ArticleDOI
Blood Pressure Lowering for the Secondary Prevention of Myocardial Infarction and Stroke
TL;DR: Questions about the safety of BP reduction for patients with preexisting cardiovascular disease have been raised following observations of J- and U-shaped associations between BP levels and the risks of recurrent myocardial infarction and stroke.